Evidence map›Paper›PMID 39596166›Full record

ArticleInternational journal of molecular sciences2024

Renoprotective Effects of Brown-Strain

Min-Min Lee, Yun-Xuan Chou, Sheng-Hsiung Huang, Hsu-Tang Cheng, Chung-Hsiang Liu, Guan-Jhong Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Cisplatin-Induced Nephrotoxicity Attenuation byInternational journal of molecular sciences · 2026
    Article
  3. The Brown Strain ofInternational journal of molecular sciences · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Min-Min LeeDepartment of Food Nutrition and Healthy Biotechnology, College of Medical and Health Sciences, Asia University, Taichung 413, Taiwan.ORCID 0000-0002-2232-9478
Yun-Xuan ChouDepartment of Food Nutrition and Healthy Biotechnology, College of Medical and Health Sciences, Asia University, Taichung 413, Taiwan.
Sheng-Hsiung HuangDepartment of Healthcare Administration, Asia University, Taichung 413, Taiwan.
Hsu-Tang ChengDepartment of Food Nutrition and Healthy Biotechnology, College of Medical and Health Sciences, Asia University, Taichung 413, Taiwan.
Chung-Hsiang LiuDepartment of Neurology, China Medical University Hospital, China Medical University, Taichung 404, Taiwan.
Guan-Jhong HuangDepartment of Food Nutrition and Healthy Biotechnology, College of Medical and Health Sciences, Asia University, Taichung 413, Taiwan.ORCID 0000-0002-9822-3485

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cisplatin, widely used in chemotherapy, acts through mechanisms such as oxidative stress to damage the DNA and cause the apoptosis of cancer cells. Although effective, cisplatin treatment is associated with considerable side effects including chronic kidney disease (CKD). Studies on brown-strain

Indexed as

CisplatinFlammulinaKidneyMice, Inbred C57BLOxidative StressRenal Insufficiency, ChronicAnimalsAntioxidantsApoptosisDisease Models, AnimalInflammationMaleMicePlant ExtractsAntioxidantsCisplatinPlant Extractsbrown-strain Flammulina velutipeschronic kidney diseasecisplatingallic acidquercetin

Identifiers

PMID39596166
PMCPMC11593982

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.